Professor Nicholson obtained his PhD from St Thomas’s Hospital Medical School, King’s College, University of London in 1980. After a series of academic appointments in Pharmacology and Chemistry at Birkbeck and University College London, he made full Professor of Biological Chemistry in 1992. He was subsequently appointed as Professor and Head of Biological Chemistry at Imperial College London in 1998 and Head the Department of Surgery and Cancer from 2009 to 2018, Director for the Centre for Gut and Digestive Health, and Director of the MRC-NIHR National Phenome Centre (2012-2018). Since 2018 he has been Emeritus Professor at Imperial College, London. He became the Pro-Vice Chancellor for Health Sciences at Murdoch University and Director of the Australian National Phenome Centre in Perth, Western Australia in 2019. One of the pioneers of biological NMR spectroscopy, metabolic phenotyping and systems medicine, his major research focus is on the development of diagnostic and prognostic molecular phenotyping analytical technologies as applied to personalised healthcare, metabolic disease, and population phenotyping. For the last 3 years he has been leading an international group working on the metabolic sequelae of and long-term complications of COVID-19. He is a “Highly-Cited” Researcher in Pharmacology and Toxicology and Cross-Field Science between 2013 and 2022 (Clarivate H index = 137, Google H = 161, 110K citations) and has received various research prizes including: The Royal Society of Chemistry (RSC) Silver (1992) and Gold (1997) Medals for Analytical Science and Analytical Chemistry respectively; The UK Chromatographic Society Jubilee Silver Medal (1994); Pfizer International Prize for Chemical and Medicinal Technology (2002); RSC medal for Chemical Biology (2003); RSC Interdisciplinary Prize (2008); Pfizer Global Research Prize for Chemistry (2006) and the Semmelweis-Budapest International Prize for Biomedicine (2010). He holds multiple visiting, and Honorary Professorships including Fudan University, Shanghai, Nanyang Technological University, Singapore, The Mayo Clinic, University of New South Wales, Shanghai Jiao Tong University, Zhejiang University, University of Western Australia, Chinese Academy of Sciences, Wuhan, and Dalian. He was elected, Fellow of The UK Academy of Medical Sciences (2010); Honorary Lifetime Fellow of the International Metabolomics Society (2012); Honorary Lifetime Member of the US Society of Toxicology (2013); Albert Einstein Honorary Professor of the Chinese Academy of Sciences (2014); Elected Honorary Fellow of the Royal College of Physicians (London) (2018); Honorary Doctor of Science, Honoris Causa (Hong Kong Baptist University), in 2020; Residential Honorary Professor – Faculty of Medicine, Khon Kaen University, Thailand (2023).